Naoki Yoshimura
Download the ICS Branding Pack
Podium Short Oral Session 21 Pain Mediators and Interventions 450 Randomized, double-blind, placebo-controlled, multicenter clinical study of the efficacy and safety of intravesical instillation of KRP-116D (50% dimethyl sulfoxide) for interstitial cystitis/bladder pain syndrome in Japanese subjects
Podium Session 5 Best Basic Science 44 Functional and molecular mechanisms underlying bladder overactivity and afferent hyperexcitability in rats with chemically induced prostatic inflammation
ICS Member
Dr Naoki Yoshimura declared on the Monday 18th July 2022 that they had the following existing or known future financial relationships or affiliations:
Scientific Committee Member